Roundtable Part II: The second installation in the Exilis Roundtable, leaders in the cosmetic industry review the Exilis - who is and who isn't the ideal patient to undergo this new radio frequency based procedure.
Roundtable Part I: As a tri-part exploration into the new mono-polar radio frequency (RF) device, Exilis, this segment explores the technology behind the Exilis and how it may differ from other devices.
Corporate support includes the leaders in cosmetic medicine such as Allergan (AGN), Medicis (MRX), Stiefel, Procter and Gamble (PG), Galderma, Sanofi Aventis (SNY), Johnson and Johnson (JNJ), Bioform (BFRM), Candela (CLZR), Palomar (PMTI), Theraplex, Neocutis, Thermage (THRM), Mentor (MNT), Reliant (RLNT), Topix and many others
The meeting will be held June 12-15th 2008 in Colorado Springs, CO featuring the leaders in aesthetic dermatology and cosmetic surgery. Topics range from cosmeceuticals to lasers, fillers to surgery, ethnic skin considerations and body shaping, and includes discussions on appropriate patient selection and technique for each